Showing promise in the arena of obesity therapy, retatrutide represents a different method. Different from many available medications, retatrutide works as a dual agonist, simultaneously engaging both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) sensors. This simultaneous activation fosters multiple beneficia… Read More